On 23 June 2017, the listed pharmaceutical company Mithra Pharmaceuticals, specialised in Women’s Health, has successfully raised EUR 26.1 million through a private placement of new shares via an accelerated bookbuilding procedure. The shares have been offered at EUR 8.40 per share and have been admitted to trading on Euronext Brussels.

For this private placement, Mithra was assisted by a Eubelius team led by Lars Van Bever, Joris De Wolf and Robin Van Gysel.